These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1664519)

  • 1. The influence of excipients and technological process on cholecalciferol stability and its liberation from tablets.
    Sawicka J
    Pharmazie; 1991 Jul; 46(7):519-21. PubMed ID: 1664519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmaceutical technology of Grandaxin].
    Fekete P
    Acta Pharm Hung; 1993 Mar; 63(2):67-78. PubMed ID: 8517166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of direct compression excipients on the stability of ascorbic acid (vitamin c) tablets.
    Ofoefule SI; Chukwube VO; Attama AA
    Boll Chim Farm; 1999 Sep; 138(8):418-21. PubMed ID: 10622107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of magnesium stearate on physical properties and biological availability of sulphadiazine tablet formulations.
    Ahmed M; Enever RP
    Pharm Acta Helv; 1978; 53(12):358-64. PubMed ID: 746045
    [No Abstract]   [Full Text] [Related]  

  • 7. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
    Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microencapsulization of cholecalciferol by coacervation].
    Sawicka J
    Pharmazie; 1990 Apr; 45(4):264-5. PubMed ID: 2166296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential scanning calorimetry to investigate the compatibility of ciprofloxacin hydrochloride with excipients.
    Fathy M; Hassan MA; Mohamed FA
    Pharmazie; 2002 Dec; 57(12):825-8. PubMed ID: 12561245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods.
    Thumma S; Repka MA
    Pharmazie; 2009 Mar; 64(3):183-9. PubMed ID: 19348341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and stability evaluation of immediate release antioxidant tablet.
    Sultana A; Hassan F; Israr F; Hasan SM; Haque N
    Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1393-400. PubMed ID: 25176233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components.
    Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M
    Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the physical properties of tablets and tablet excipients. V. Film coating for protection of a light-sensitive tablet-formulation.
    Nyqvist H; Nicklasson M; Lundgren P
    Acta Pharm Suec; 1982; 19(3):223-8. PubMed ID: 7113729
    [No Abstract]   [Full Text] [Related]  

  • 19. [Production and assessing release of imipramine and magnesium from tablets].
    Kasperek R; Zimmer Ł; Szalast-Pietrzak A; Marzec Z; Poleszak E
    Polim Med; 2014; 44(4):247-53. PubMed ID: 25932906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.
    Brange J; Langkjaer L
    Acta Pharm Nord; 1992; 4(3):149-58. PubMed ID: 1418641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.